在免疫抑制中接种疫苗的挑战和建议
Caroline Alves de Oliveira Martins1, Isabella Ballalai2, Juarez Cunha3
1Universidade Federal Fluminense Rio de JaneiroRJ Brazil 1-Universidade Federal Fluminense, Rio de Janeiro, RJ, Brazil; Comissão Nacional Especializada de Vacinas da Federação Brasileira das Associações de Ginecologia e Obstetrícia (Febrasgo), Brazil.
概括
免疫缺陷患者面临感染风险增加和疫苗反应较弱. 该审查澄清了针对免疫抑制患者的疫苗推和计划,帮助医疗保健提供者.
科学领域:
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
- 公共卫生 公共卫生
背景情况:
- 与一般人群相比,免疫缺陷患者对严重感染的易感性增加,疫苗有效性降低.
- 感染对免疫功能受损的个体构成重大健康风险和并发症.
研究的目的:
- 审查免疫抑制群体中疫苗的疗效和安全性.
- 为适当的疫苗接种策略提供指导,包括疫苗选择,最佳时间和再接种计划.
- 更新妇科医生和妇产科医生关于免疫受损患者接种疫苗的指导方针.
主要方法:
- 对免疫抑制个体疫苗有效性和安全性研究的文献综述.
- 分析当前的疫苗接种指南和建议.
- 汇编关于巴西国家免疫计划和可用的疫苗接种服务的信息.
主要成果:
- 由于免疫反应的改变,免疫受损的个体需要特定的疫苗接种方案.
- 有证据支持某些疫苗在免疫抑制群体中安全和有效,当它们被正确使用时.
- 最佳的疫苗接种时间和再接种对于最大限度地保护至关重要.
结论:
- 特定的疫苗适用于免疫抑制个体,精确的注射时间和再接种计划是必不可少的.
- 医疗保健提供者,特别是妇科医生和产科医生,需要更新关于疫苗接种这一脆弱群体的信息.
- 遵守推的疫苗接种计划可以增强对感染的保护,并改善免疫受损者的健康结果.
相关概念视频
01:25Immunodeficiency Diseases
1.9K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
1.9K
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
01:29Pulmonary Tuberculosis I
822
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
822
01:51Vaccinations
51.2K
Overview
51.2K
01:22Development of Immunocompetence
789
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
789
01:30Cancer Vaccines
952
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
952